Cyro von Zuben de Valega Negrão

Cyro von Zuben de Valega Negrão

Auto-generated profile, based on publicly available information

Cyro von Zuben de Valega Negrão

Brazilian Center for Research in Energy & Materials (CNPEM), Brazilian Biosciences National Laboratory (LNBio), Campinas, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Nanomedicine
Verified
Journal Article
Closed access
CNCyro von Zuben de Valega Negrão
Cyro von Zuben de Valega Negrão
NCNatália Neto Pereira Cerize
Natália Neto Pereira Cerize
AJAmauri da Silva Justo-Junior
Amauri da Silva Justo-Junior
RLRaquel Bester Liszbinski
Raquel Bester Liszbinski
GMGiovanna Pastore Meneguetti
Giovanna Pastore Meneguetti
SDSandra Dias
Sandra Dias
Aim: To synthesize HER2 aptamer-conjugated iron oxide nanoparticles with a coating of poly(2-(dimethylamino) ethyl methacrylate)–poly(2-methacryloyloxyethylphosphorylcholine) block copolymer (IONPP...

14 May 2025 in ACS Omega
Verified
Journal Article
Open access
LSLuiz Henrique Mesquita Souza
Luiz Henrique Mesquita Souza
IDIanca Rosa Dias
Ianca Rosa Dias
CNCyro von Zuben de Valega Negrão
Cyro von Zuben de Valega Negrão
HOHenrique da Costa Oliveira
Henrique da Costa Oliveira
PTPaula Cristina Gasperazzo Turrini
Paula Cristina Gasperazzo Turrini
NCNatália Neto Pereira Cerize
Natália Neto Pereira Cerize
Leveraging the well-established properties of gold nanoparticle (AuNP)-DNA conjugates, this research explored a novel methodology for controlled enzymatic DNA synthesis using gold nanoparticle (AuNP)-DNA conjugates as a solid platform. To this end, Hybrid Nanoparticles (HNPs) were meticulously engineered through the functionalization of AuNPs with rationally designed DNA initiator molecules. These initiator molecules, strategically attached to the AuNP surface, served as a physical support and starting point for DNA extension by the Terminal Deoxynucleotidyl Transferase (TdT) enzyme. The results confirmed the synthesis of homopolymeric DNA extensions on these HNPs (58.27 nm, PDI < 0.2), demonstrating the viability of HNPs as a platform for enzymatic DNA elongation. Although the growing demand for data storage suggests a potential application, this research established the foundational feasibility of enzymatic DNA synthesis on HNPs. While high-density DNA data storage requires extensive development, the demonstrated enzymatic synthesis on AuNP-DNA conjugates warrants significant further exploration for future applications in biotechnology and nanotechnology.

13 March 2026 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Open access
GGGuilherme Giovanini
Guilherme Giovanini
CNCyro von Zuben de Valega Negrão
Cyro von Zuben de Valega Negrão
Ammar AlsinaiAmmar Alsinai
Ammar Alsinai
MRMarsha Rosner
Marsha Rosner
Gábor BalázsiGábor Balázsi
Gábor Balázsi
Alexandre RamosAlexandre Ramos
Alexandre Ramos
Cell phenotype dynamic homeostasis contrasts with the inherent randomness of intracellular reactions. Although feedback control of regulator genes (RG) is a key strategy for limiting the range of downstream gene expression, understanding the quantitative constraints and corresponding mechanisms enabling such a dynamic stability under noise remains elusive. Here we model RG expression as a stochastic process and downstream genes as sensors whose responses conditionally induce RG activity. We show that at homeostatic regime: i. the trajectories of the RG expression levels can be adjusted towards specific ranges using both the exact solutions of the stochastic model and the exact stochastic simulation algorithm (SSA); ii. there exists a sampling rate which optimizes the feedback control of the RG activity, and non-optimal controls resulting in alternative homeostatic dynamics; iii. the feedback control of RG activity leads to updates whose intensities and time intervals are non-linearly related; iv. the ON state probability of an RG promoter has dynamics confined within a narrow domain. Our results help to understand the quantitative constraints underpinning dynamic homeostasis despite randomness, the mechanisms underlying alternative, non-optimal, homeostatic regimes, and may be useful for theoretically prototyping therapies aiming at gene network modulation.

8 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CNCyro von Zuben de Valega Negrão
Cyro von Zuben de Valega Negrão
NCNatália Neto Pereira Cerize
Natália Neto Pereira Cerize
AJAmauri da Silva Justo-Junior
Amauri da Silva Justo-Junior
RLRaquel Bester Liszbinski
Raquel Bester Liszbinski
GMGiovanna Pastore Meneguetti
Giovanna Pastore Meneguetti
SDSandra Dias
Sandra Dias
Hybrid nanoparticles have shown promise in biomedical applications; however, their seamless integration into clinical settings remains challenging. Here, we introduce a novel metal oxide polymer hybrid nanoparticle (NP) with a high affinity for nucleic acids. Iron oxide nanoparticles (IONP) were initially synthesized via the co-precipitation method and subjected to comprehensive characterization. Subsequently, block copolymers were synthesized using the Reversible Addition−Fragmentation Chain Transfer (RAFT) technique, employing the zwitterionic PMPC (Poly (2 Methacryloyloxyethyl Phosphorylcholine)) and the cationic PDMAEMA (Poly(2 (Dimethylamino) Ethyl Methacrylate)) with varying degrees of polymerization. In vitro cytotoxicity studies demonstrated the biocompatibility of the synthesized nanoparticles, with no observed toxicity up to a concentration of 150 µg/mL. The cationic polymer PDMAEMA facilitated the facile coating of IONP, forming the IONPP complex, consisting of a 13.27 metal core and a 3.1 nm block-copolymer coating. Subsequently, the IONPP complex was functionalized with a DNA aptamer specifically targeting the human epidermal growth factor receptor 2 (HER2) in breast cancer, forming IONPPP. The block-copolymer exhibited an EC 50 of 7.07 µg/mL and demonstrated enhanced recognition efficiency in HER2-amplified SKBR3 cells. Our study presents a comprehensive IONPPP characterization capable of binding short DNA sequences and targeting proteins such as HER2. This newly developed nanoparticle holds significant potential for cancer cell identification and isolation, offering promising prospects in cancer research and clinical applications. 1. Statement of significance: Despite recent advancements in biomedical research, developing sensitive and specific tools for recognizing biological motifs, such as cell receptors and proteins in complex biological solutions, remains a challenge. Furthermore, current approaches often rely on complex biological derivatives like antibodies, lacking a cost-effective delivery strategy. Our study proposes creating and characterizing a novel hybrid metal oxide polymer nanoparticle named IONPPP, functionalized with a DNA aptamer designed to recognize HER2-positive cells. HER2 is a clinically actionable marker for gastric, gastroesophageal, and, particularly, breast cancers. This unique combination of a metal core with an external polymeric structure offers the potential for identification, isolation, and even theragnostic applications, benefiting from its low toxicity and high specificity. 2. Graphical

9 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CNCyro von Zuben de Valega Negrao
Cyro von Zuben de Valega Negrao
HHHaley Hendrick
Haley Hendrick
FAFarah Ammar
Farah Ammar
RKRemi V. Klotz
Remi V. Klotz
SDSandra Dias
Sandra Dias
MYMin Yu
Min Yu
Metastasis remains the major cause of cancer-related mortality, and circulating tumor cells (CTCs) are both candidate liquid-biopsy biomarkers and plausible intermediates of metastatic dissemination. Because CTCs are extremely rare in peripheral blood, platform comparisons have often focused solely on recovery. That focus is insufficient for applications that depend on the quality of the recovered material, including single-cell profiling, short-term culture, and functional testing. Here, we compared four CTC isolation approaches: TellDx CTC System, Genesis System, RosetteSep™, and flow cytometry, using spike-in experiments in human blood. Capture efficiency was evaluated across all four platforms; purity was assessed for TellDx, Genesis, and RosetteSep™; and post-isolation GFP signal persistence in culture was assessed for TellDx and Genesis as an exploratory proxy for short-term post-isolation preservation. Under the conditions tested, TellDx showed the highest recovery (88.1% ± 3.7%), followed by Genesis (40.6% ± 12.1%), RosetteSep™ (36.5% ± 9.0%), and flow cytometry (7.6% ± 4.5%). TellDx also showed the highest purity score (3.76), whereas Genesis (2.25) and RosetteSep™ (2.09) did not differ substantially. In the short-term culture assay, TellDx-derived samples retained a higher normalized GFP signal than Genesis-derived samples at 48 h and 72 h. To synthesize these readouts, we propose the Recovery Performance Index (RPI), a composite score integrating recovery, purity, and post-isolation signal persistence. Within this experimental framework, TellDx achieved the highest RPI. These data support two conclusions. First, platform benchmarking for CTC workflows benefits from multidimensional evaluation rather than recovery alone. Second, under this spike-in model and within the specific workflows used here, TellDx performed best among the platforms tested. The principal contribution of this study is therefore the establishment of a practical benchmarking framework that can be expanded in future work using clinical samples, multiple CTC phenotypes, and orthogonal viability assays.

22 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAnelise G. Silva
Anelise G. Silva
ISIzaque J. O. Silva
Izaque J. O. Silva
PTPedro P. Tanaka
Pedro P. Tanaka
MMMatheus Z. Monteiro
Matheus Z. Monteiro
SFSérgio Servilha Oliveira Filho
Sérgio Servilha Oliveira Filho
CNCyro. Z. V. Negrão
Cyro. Z. V. Negrão
Breast cancer is a heterogeneous disease comprising molecular subtypes with distinct therapeutic vulnerabilities. Among emerging therapeutic strategies, copper-based nanoparticles have shown anticancer activity. However, whether these responses differ across breast cancer subtypes and which molecular programs underlie copper sensitivity remain poorly understood. We investigated subtype-specific responses to Polyvinylpyrrolidone-assisted copper nanoparticles (CuNP-PVP) in breast cancer cell lines and the molecular programs underlying copper adaptation. CuNP-PVP were synthesized and evaluated in luminal (MCF-7), HER2-positive (SKBR3), and triple-negative (MDA-MB-231) breast cancer cell lines, with transcriptomic analyses integrated with CCLE and TCGA-BRCA datasets. UV-Vis spectroscopy revealed a plasmon resonance band at 591 nm, while TEM showed spherical nanoparticles with an average diameter of 76.1 ± 21.0 nm. DLS indicated a larger hydrodynamic diameter, consistent with PVP coating; ζ-potential measurements showed a surface charge of −13 mV, and XPS confirmed mixed reduced and Cu(I)/Cu(II) oxidation states. Exposure to 100 μg/mL CuNP-PVP induced subtype-dependent effects on cell viability, with MCF-7 showing greater sensitivity, whereas MDA-MB-231 and SKBR3 were less affected. Baseline transcriptomic analyses revealed enrichment of oxidative stress, metabolic adaptation, and lysosomal programs in less sensitive cells, whereas MCF-7 showed higher expression of lipoylation-related genes. These features supported the development of a Potential Biological Copper-Response Index (PBCRI), which captured subtype-associated transcriptional patterns across independent cell lines and patient tumors, with luminal models showing lower scores and basal/TNBC models showing higher scores. Together, these findings identify candidate transcriptional programs associated with subtype-specific responses to CuNP and provide a framework for investigating potential molecular determinants of copper sensitivity. Highlights: PVP-assisted copper nanoparticles showed mixed metallic/oxidized Cu phases. CuNP-PVP induced cell-dependent cytotoxicity in breast cancer cells. MCF-7 cells were more sensitive to CuNP-PVP than TNBC and HER2+ cells. Baseline profiles differed in lipoylation, antioxidant, and lysosomal programs. PBCRI captured subtype-associated copper-response transcriptional patterns.